- Stocks
- Pharma & Healthcare
- Aster DM Health
Aster DM Health share price
NSE: ASTERDMPharma & HealthcareMedical Care Facilities
Aster DM Health at a glance
Aster DM Health (NSE: ASTERDM) closed at ₹667.80 on 21 Oct 2026, down 0.06% on the day. With a market capitalisation of ₹58,210 Cr, it ranks 177th by market cap among the 4,183 NSE companies Pivot tracks (a mid-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.
At its last close the stock traded at 104.3× trailing earnings, against a return on equity of 8.5% in FY26. Over the past year the share price has fallen 4.8%. Its 52-week range is ₹519.10 (4 Feb 2026) to ₹891.30 (10 Aug 2026); the last close is 25.1% below the high.
Key numbers
- Market cap
- ₹58,210 CrRank 177 on NSE
- P/E (trailing)
- 104.3×
- Price to book
- 7.6×FY26
- ROE
- 8.5%FY26
- ROCE
- 10.7%FY26
- Debt to equity
- 0.15FY26
- Net profit margin
- 10.0%FY26
- Book value / share
- ₹88.31FY26
- 52-week high
- ₹891.3010 Aug 2026
- 52-week low
- ₹519.104 Feb 2026
- 1-year return
- −4.8%
- RSI (14-day)
- 34
Returns to 21 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −0.06% | −3.4% | −11.3% | −18.2% | −4.8% |
Aster DM Health financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹8,608 Cr | ₹10,253 Cr | ₹11,933 Cr | ₹3,699 Cr | ₹4,138 Cr | — |
| Operating profit | ₹202 Cr | ₹636 Cr | ₹534 Cr | ₹273 Cr | ₹540 Cr | — |
| Net profit | ₹174 Cr | ₹601 Cr | ₹474 Cr | ₹223 Cr | ₹5,427 Cr | — |
| EPS (₹) | ₹3.00 | ₹11.00 | ₹9.00 | ₹3.00 | ₹108.00 | — |
| Cash from operations | ₹1,569 Cr | ₹1,313 Cr | ₹1,834 Cr | ₹158 Cr | ₹425 Cr | — |
| Total debt | ₹1,755 Cr | ₹1,466 Cr | ₹1,312 Cr | ₹446 Cr | ₹484 Cr | ₹558 Cr |
| Shareholders' equity | ₹3,372 Cr | ₹3,953 Cr | ₹4,074 Cr | ₹4,560 Cr | ₹3,428 Cr | ₹4,576 Cr |
Aster DM Health vs peers
The listed Pharma & Healthcare companies nearest to Aster DM Health by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| GLENMARKGlenmark Pharmaceuticals | ₹2,214.30 | +0.65% | +15.7% | ₹62,488 Cr | 45.8 | 12.9% |
| ALKEMAlkem Laboratories | ₹5,016.00 | +0.80% | −9.0% | ₹59,974 Cr | 26.1 | 16.6% |
| ASTERDMAster DM Health | ₹667.80 | −0.06% | −4.8% | ₹58,210 Cr | 104.3 | 8.5% |
| FORTISFortis Healthcare | ₹736.65 | +0.22% | −32.7% | ₹55,614 Cr | 53.5 | 10.5% |
| BIOCONBiocon | ₹340.35 | −0.07% | −2.7% | ₹55,467 Cr | 120.3 | 1.1% |
| ABBOTINDIAAbbott India | ₹25,895.00 | −0.37% | −13.7% | ₹55,025 Cr | 35.4 | 33.4% |
| GLANDGland Pharma | ₹2,975.90 | −1.79% | +54.0% | ₹49,090 Cr | 47.8 | 9.9% |
Ask anything about Aster DM Health
Pivot answers on the live chart with evidence you can check, and tests strategies against ASTERDM's own history. Try: “Why has ASTERDM moved over the last three months?” · “Backtest a 50-day moving-average crossover on ASTERDM over five years” · “Compare ASTERDM with GLENMARK on margins and valuation”
Frequently asked questions about Aster DM Health
What is the share price of Aster DM Health today?
Aster DM Health (NSE: ASTERDM) last closed at ₹667.80 on 21 Oct 2026. Its 52-week high is ₹891.30 and its 52-week low is ₹519.10.
What is the market cap of Aster DM Health?
Aster DM Health's market capitalisation is ₹58,210 Cr (₹58,210 Cr) at the 21 Oct 2026 close, ranking 177th among the NSE companies Pivot tracks.
What is the P/E ratio of Aster DM Health?
Aster DM Health trades at a trailing P/E of 104.3. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 47.8.
What is the ROE and ROCE of Aster DM Health?
Return on equity was 8.5% in FY26 and return on capital employed was 10.7% in FY26 (consolidated figures).
Is Aster DM Health a debt-free company?
No. Aster DM Health's debt-to-equity ratio was 0.15 in FY26, with total debt of ₹2,299 Cr.
How has Aster DM Health stock performed over the last year?
Aster DM Health's share price has fallen 4.8% over the past year, −18.2% over three months and −11.3% over one month, to the 21 Oct 2026 close.
Who are Aster DM Health's competitors?
The listed Pharma & Healthcare companies closest to Aster DM Health by market cap are Glenmark Pharmaceuticals, Alkem Laboratories, Fortis Healthcare, Biocon, Abbott India and Gland Pharma.
Is Aster DM Health a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Aster DM Health's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ASTERDM against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 21 Oct 2026 (returns and ratios at the 21 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with A · all NSE stocks · this page as text